advertisement

---

Xue J 8

Showing records 1 to 8 | Display all abstracts from Xue J

128774 Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Lin Z; Xue J
Frontiers in pharmacology 2025; 16: 1623921

---

127642 Levels of Zinc, Iron, and Copper in the Aqueous Humor of Patients with Primary Glaucoma
Liu Z
Biomolecules 2025; 15:

---

128774 Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Yang M
Frontiers in pharmacology 2025; 16: 1623921

---

127642 Levels of Zinc, Iron, and Copper in the Aqueous Humor of Patients with Primary Glaucoma
Li Z
Biomolecules 2025; 15:

---

128774 Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Yu X
Frontiers in pharmacology 2025; 16: 1623921

---

127642 Levels of Zinc, Iron, and Copper in the Aqueous Humor of Patients with Primary Glaucoma
Zhu Y
Biomolecules 2025; 15:

---

128774 Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
Zhong J
Frontiers in pharmacology 2025; 16: 1623921

---

127642 Levels of Zinc, Iron, and Copper in the Aqueous Humor of Patients with Primary Glaucoma
Liang S; Liu H; Xue J; Lin J; Deng Y; Deng C; Zeng S; Zhuo Y; Li Y
Biomolecules 2025; 15:

---